JUN 04, 2020 6:30 AM PDT

Low T Cells Linked To High COVID Risk

WRITTEN BY: Tara Fernandez

German scientists have identified a connection between immune cell counts and the risk of developing severe, potentially life-threatening symptoms of COVID-19. The team, led by professor of virology, Ulf Dittmer, found that people who have low T cell counts at the time of infection have higher odds of developing a severe form of COVID-19. The study was published in the medical journal, The Lancet.

The numbers of a particular subpopulation of T cells, called cytotoxic T cells, in the blood were found to be central to this response. These immune cells protect the body by killing cancerous or virally-infected cells. 

It’s not just the number of T cells that count. The ratio of cytotoxic T cells to another type of immune cell, neutrophils, was also found to be important. T cells and neutrophils serve different but complementary roles in the protective immune response and have strong regulatory effects on each other.

“If there are too many neutrophils in the blood, they tend to suppress the function of T-cells. It can, therefore, be assumed that an elevated number of neutrophils in COVID-19 patients might contribute to a decrease in T cell counts,” explained Dittmer.

Common initial symptoms following coronavirus infection include fever, cough, fatigue, and diarrhea. More severe symptoms typically develop around a week later, in which the conditions of these patients rapidly deteriorate as acute respiratory distress syndrome, or ARDS, sets in. As symptoms progress, COVID-19 has also led to heart, kidney and liver damage and, in the worst cases, death. Being able to identify patients most at risk would allow physicians to initiate intensive interventions earlier and improve clinical outcomes.

 

 

The team’s investigation looked at 40 COVID-19 patients in Wuhan, China. Their studies suggest that a simple blood test for T cell and neutrophil counts should be done to quickly pick out at-risk COVID-19 patients. These patients need to be monitored more closely and perhaps be treated at an earlier stage, said Dittmer.

Patients receiving medications or therapies that can damage T cells, such as chemotherapy, should also be more closely monitored given this finding. 

The team’s finding also has implications for the development of a vaccine against the virus that causes COVID-19, SARS-CoV-2. A vaccine capable of shielding against infection may not only need to trigger the production of antibodies, but also activate T cell responses in order to confer robust protection.

 

Sources: Innovation Origins, The Lancet, The New England Journal of Medicine.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
DEC 03, 2020
Clinical & Molecular DX
Spit Contains Concussion Clues
DEC 03, 2020
Spit Contains Concussion Clues
Drowsiness, confusion, headaches, and sensitivity to light — it’s sometimes hard for doctors to spot the sig ...
DEC 03, 2020
Neuroscience
Scientists Invent Noninvasive Microscope to Observe Neurons
DEC 03, 2020
Scientists Invent Noninvasive Microscope to Observe Neurons
To obtain high-resolution images of the brain, researchers usually need to reduce the thickness of the skull or cut into ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
FEB 17, 2021
Clinical & Molecular DX
Urine Test Bypasses the Need for Prostate Biopsies
FEB 17, 2021
Urine Test Bypasses the Need for Prostate Biopsies
Researchers have created a urine test for prostate cancer that could make unnecessary biopsies a thing of the past. The ...
FEB 16, 2021
Genetics & Genomics
Genetic Tests That Look for Rare, Disease-Causing Variants are Usually Wrong
FEB 16, 2021
Genetic Tests That Look for Rare, Disease-Causing Variants are Usually Wrong
While people carry mostly the same genes, there are small differences in the sequences of those genes that can have prof ...
Loading Comments...